A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot …
I Ofotokun, AN Sheth, SE Sanford… - AIDS research and …, 2012 - liebertpub.com
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot …
I Ofotokun, AN Sheth, SE Sanford… - AIDS Research and …, 2012 - europepmc.org
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
[HTML][HTML] A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected …
I Ofotokun, AN Sheth, SE Sanford… - AIDS Research and …, 2012 - ncbi.nlm.nih.gov
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot …
I Ofotokun, AN Sheth, SE Sanford, KA Easley, N Shenvi… - 2012 - cabidigitallibrary.org
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
[引用][C] A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected …
I Ofotokun, AN Sheth, SE Sanford, KA Easley… - AIDS Research and …, 2012 - cir.nii.ac.jp
A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir
and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial …
and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial …
[引用][C] A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected …
I OFOTOKUN, AN SHETH… - AIDS research and …, 2012 - pascal-francis.inist.fr
A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir
and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial …
and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial …
[PDF][PDF] A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected …
I Ofotokun, AN Sheth, SE Sanford… - AIDS RESEARCH …, 2012 - academia.edu
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot …
I Ofotokun, AN Sheth, SE Sanford, KA Easley, N Shenvi… - 2012 - pubmed.ncbi.nlm.nih.gov
A nucleoside reverse transcriptase inhibitor (NRTI) backbone is a recommended component
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …
of standard highly active antiretroviral therapy (sHAART). However, long-term NRTI …